Sino-Swed Tong Kang

Sino-Swed Tong Kang Bio-Tech (Shenzhen) Co., Ltd. is an innovative biotechnology company that carries the Swedish concept of value-based medicine. The company is committed to the development and establishment of major disease risk assessment technologies and platforms, and cooperates with scientific research institutions to realize the industrialization transformation of major cutting-edge scientific research achievements. With TK1 (thymidine kinase 1) as its core technology, Sino-Swed Tong Kang has owned multiple international/domestic invention patents in biotechnology and multiple SFDA product registration certificates. It has established IgY special antibody R&D and production bases in China and Sweden, and has passed medical device GMP certification and ISO13485 internationally recognized quality management system certification. With leading R&D capabilities, a mature market network, and advanced management models, Sino-Swed Tong Kang adheres to the purpose of "technology dedicated to humanity" and is committed to serving human health.

Company benefits:
1. The company implements a 5-day work system and employees enjoy paid holidays such as national statutory holidays, marriage leave, maternity leave, and annual leave in accordance with the law;
2. Pension, medical, maternity, work-related injury, unemployment insurance, and housing provident fund are paid in accordance with national regulations;
3. A young, energetic, proactive, and united team, a spacious and comfortable office environment, and a friendly and mutually supportive humanistic environment;
4. The company provides professional training in skills and management knowledge, offers corresponding career planning guidance for employees, and provides outstanding employees with opportunities for overseas training and work.